Wayne Blosser

1.4k citations

19 papers · 637 indexed · h-index 15

Impact in

Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Biophysics top 5%
- Cell Image Analysis Techniques

Papers in ⓘ

Biophysics 3
- Cell Image Analysis Techniques 3
Genetics 4

Co-authors: Louis F. Stancato (15 shared papers)Michele Dowless (12 shared papers)Mark S. Marshall (2 shared papers)Darlene Barnard (2 shared papers)David A. Barda (2 shared papers)Constance King (2 shared papers)Richard P. Beckmann (4 shared papers)Jack Dempsey (3 shared papers)
Journals: Molecular Cancer Therapeutics (4 papers)Clinical Cancer Research (3 papers)Oncotarget (3 papers)SLAS DISCOVERY (2 papers)PLoS ONE (2 papers)
Partner nations: United States Italy Egypt

In The Last Decade

Wayne Blosser

19 papers receiving 631 citations

Peers

Countries citing papers authored by Wayne Blosser

Since Specialization

Citations

This map shows the geographic impact of Wayne Blosser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Blosser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Blosser more than expected).

Fields of papers citing papers by Wayne Blosser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne Blosser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Blosser. The network helps show where Wayne Blosser may publish in the future.

Co-authors

The 25 scholars most cited alongside Wayne Blosser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wayne Blosser Line = papers co-authored together Wayne Blosser links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms Molecular Cancer Therapeutics ·Constance King, H. Bruce Diaz, Samuel McNeely, Darlene Barnard, Jack Dempsey, Wayne Blosser, Richard P. Beckmann, David A. Barda, Mark S. Marshall	2015	139
2	Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor Investigational New Drugs ·Constance King, Henry Diaz, Darlene Barnard, David A. Barda, David K. Clawson, Wayne Blosser, Karen L. Cox, Sherry Guo, Mark S. Marshall	2013	90
3	LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer Oncotarget ·Eliza Vakana, Susan E. Pratt, Wayne Blosser, Michele Dowless, Nicholas Simpson, Xiu‐Juan Yuan, Susan Jaken, Jason R. Manro, Jennifer R. Stephens, Youyan Zhang, Lysiane Huber, Sheng-Bin Peng, Louis F. Stancato	2016	54
4	The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma Clinical Cancer Research ·Caitlin D. Lowery, Alle B. VanWye, Michele Dowless, Wayne Blosser, Beverly L. Falcón, Julie Stewart, Jennifer R. Stephens, Richard P. Beckmann, Aimee Bence Lin, Louis F. Stancato	2017	53
5	Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling Clinical Cancer Research ·Michele Dowless, Caitlin D. Lowery, Terry J. Shackleford, Matthew Renschler, Jennifer Stephens, Robert S. Flack, Wayne Blosser, Simone Gupta, Julie Stewart, Yue Webster, Jack Dempsey, Alle B. VanWye, Philip J. Ebert, Philip W. Iversen, Jonathan B. Olsen, Xueqian Gong, Sean G. Buchanan, Peter J. Houghton, Louis F. Stancato	2018	47
6	LY2228820 Dimesylate, a Selective Inhibitor of p38 Mitogen-activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formation in Vitro and in Vivo Journal of Biological Chemistry ·Courtney M. Tate, Wayne Blosser, Lisa Wyss, Glenn F. Evans, Qi Xue, Yong Pan, Louis F. Stancato	2013	37
7	Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization Molecular Cancer Therapeutics ·Timothy I. Meier, Mark Uhlik, Sudhakar Chintharlapalli, Michele Dowless, Robert Van Horn, Julie Stewart, Wayne Blosser, James A. Cook, Debra A. Young, Xiang Ye, Glenn F. Evans, Kelly M. Credille, Darryl Ballard, Lysiane Huber, Andrew Capen, Márcio F. Chedid, Robert Ilaria, Michèle C. Smith, Louis F. Stancato	2011	31
8	High-content imaging characterization of cell cycle therapeutics through in vitro and in vivo subpopulation analysis Molecular Cancer Therapeutics ·Jonathan Low, Shuguang Huang, Wayne Blosser, Michele Dowless, John B.E. Burch, Blake Lee Neubauer, Louis F. Stancato	2008	29
9	A Robust High-Content Imaging Approach for Probing the Mechanism of Action and Phenotypic Outcomes of Cell-Cycle Modulators Molecular Cancer Therapeutics ·Jeffrey J. Sutherland, Jonathan Low, Wayne Blosser, Michele Dowless, Thomas A. Engler, Louis F. Stancato	2011	26
10	Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α Clinical Cancer Research ·Caitlin D. Lowery, Wayne Blosser, Michele Dowless, Shelby M. Knoche, Jennifer R. Stephens, Huiling Li, David Surguladze, Nick Loizos, Debra Luffer‐Atlas, Gerard J. Oakley, Qianxu Guo, Seema Iyer, Brian P. Rubin, Louis F. Stancato	2017	26
11	Phenotypic Fingerprinting of Small Molecule Cell Cycle Kinase Inhibitors for Drug Discovery PubMed ·Jonathan Low, Arunava Chakravartty, Wayne Blosser, Michele Dowless, Christopher Chalfant, Patty Bragger, Louis F. Stancato	2009	19
12	Efficacy of LY2784544, a Small Molecule Inhibitor Selective for Mutant JAK2 Kinase, In JAK2 V617F-Induced Hematologic Malignancy Models Blood ·Liandong Ma, Baohui Zhao, Richard A. Walgren, Joshua A Clayton, Wayne Blosser, Timothy P. Burkholder, Michèle C. Smith	2010	16
13	A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology PLoS ONE ·Courtney M. Tate, Jacquelyn Mc Entire, Roberto Pallini, Eliza Vakana, Lisa Wyss, Wayne Blosser, Lucia Ricci‐Vitiani, Quintino Giorgio D’Alessandris, Liliana Morgante, Stefano Giannetti, Luigi Maria Larocca, Matilde Todaro, Antonina Benfante, Maria Luisa Colorito, Giorgio Stassi, Ruggero De Maria, Scott W. Rowlinson, Louis F. Stancato	2015	14
14	High-Content Imaging Analysis of the Knockdown Effects of Validated siRNAs and Antisense Oligonucleotides SLAS DISCOVERY ·Jonathan Low, Shuguang Huang, Michele Dowless, Wayne Blosser, Thomas M. Vincent, Scott Davis, Jeff Hodson, Erich Koller, Eric G. Marcusson, Kerry Blanchard, Louis F. Stancato	2007	14
15	Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy Oncotarget ·Caitlin D. Lowery, Wayne Blosser, Michele Dowless, Matthew Renschler, Lisa V. Perez, Jennifer R. Stephens, Bronislaw Pytowski, Heather Wasserstrom, Louis F. Stancato, Beverly L. Falcón	2019	14
16	A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Oncotarget ·Wayne Blosser, Jack Dempsey, Ann M. McNulty, Xi Rao, Philip J. Ebert, Caitlin D. Lowery, Philip W. Iversen, Yue Webster, Gregory P. Donoho, Xueqian Gong, Farhana F. Merzoug, Sean G. Buchanan, Karsten Boehnke, Chunping Yu, Xintian You, Richard P. Beckmann, Wenjuan Wu, Samuel McNeely, Aimee Bence Lin, Ricardo Martínez	2020	13
17	Knockdown of Ubiquitin Ligases in Glioblastoma Cancer Stem Cells Leads to Cell Death and Differentiation SLAS DISCOVERY ·Jonathan Low, Wayne Blosser, Michele Dowless, Lucia Ricci‐Vitiani, Roberto Pallini, Ruggero De Maria, Louis F. Stancato	2011	10
18	A Method to Assess Target Gene Involvement in Angiogenesis In Vitro and In Vivo Using Lentiviral Vectors Expressing shRNA PLoS ONE ·Wayne Blosser, Eliza Vakana, Lisa Wyss, Michelle L. Swearingen, Julie Stewart, Louis F. Stancato, Courtney M. Tate	2014	4
19	Abstract 2458: Targeting checkpoint kinase 1 (CHK1) with the small molecule inhibitor LY2606368 mesylate monohydrate in models of high-risk pediatric cancer yields significant antitumor effects Cancer Research ·Caitlin D. May, Richard P. Beckmann, Wayne Blosser, Michele Dowless, Alle B. VanWye, Teresa F. Burke, Gerard J. Oakley, Jennifer R. Stephens, Julie Stewart, Beverly L. Falcón, Louis F. Stancato	2016	1

About Wayne Blosser

Wayne Blosser is a scholar working on Biophysics, Genetics, Oncology, Media Technology and Neurology, having authored 19 papers that have together received 637 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Cell Image Analysis Techniques (3 papers), Angiogenesis and VEGF in Cancer (3 papers), DNA Repair Mechanisms (3 papers), Neuroblastoma Research and Treatments (3 papers), Image Processing Techniques and Applications (2 papers), Protein Degradation and Inhibitors (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Oncology (310 citations), Biophysics (49 citations), Molecular Biology (464 citations), Cancer Research (69 citations) and Genetics (45 citations). Wayne Blosser has collaborated with scholars based in United States, Italy and Egypt. Frequent co-authors include Louis F. Stancato, Michele Dowless, Mark S. Marshall, Darlene Barnard, David A. Barda, Constance King, Richard P. Beckmann, Jack Dempsey, Samuel McNeely and Jonathan Low. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Oncotarget, SLAS DISCOVERY and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact